ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Two Trials Presented at ASCO Demonstrate Drop in Death Risk, Increased Survival

June 24, 2011

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

Includes June issue of Business & Regulatory Report.

June 28, 2002

Healy Sworn In, Calls For ‘Operation Bethesda Storm’

July 12, 1991

Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds

August 27, 2004

NIH Offers Curriculum Supplements For K-12

November 5, 1999